This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Shunji Kunori: Innovator in Analgesic Tolerance Inhibition
Introduction
Shunji Kunori is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of agents that address the undesirable effects of opioid-type analgesics. His work is crucial in the ongoing battle against pain management challenges.
Latest Patents
Kunori holds a patent for an "Inhibitor of Analgesic Tolerance." This invention provides an agent for suppressing the undesirable effects of opioid-type analgesics, specifically targeting issues such as analgesic tolerance and constipation. The active ingredient in this agent is a compound with adenosine A receptor antagonistic activity or a pharmaceutically acceptable salt thereof. This innovation is vital for improving patient outcomes in pain management.
Career Highlights
Shunji Kunori is associated with Kyowa Hakko Kirin Co., Limited, where he has been instrumental in advancing research and development in the pharmaceutical sector. His expertise and innovative approach have led to significant advancements in the field.
Collaborations
Kunori has collaborated with esteemed colleagues, including Yozo Kojima and Katsutoshi Sasaki. Their combined efforts have contributed to the success of various projects within the company.
Conclusion
Shunji Kunori's work in developing inhibitors for analgesic tolerance represents a significant advancement in pain management. His contributions continue to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile